Small molecule screening in context

Lipid-catalyzed amyloid formation

James A. Hebda, Mazin Magzoub, Andrew D. Miranker

Research output: Contribution to journalArticle

Abstract

Islet Amyloid Polypeptide (IAPP) is a 37-residue hormone cosecreted with insulin by the β-cells of the pancreas. Amyloid fiber aggregation of IAPP has been correlated with the dysfunction and death of these cells in type II diabetics. The likely mechanisms by which IAPP gains toxic function include energy independent cell membrane penetration and induction of membrane depolarization. These processes have been correlated with solution biophysical observations of lipid bilayer catalyzed acceleration of amyloid formation. Although the relationship between amyloid formation and toxicity is poorly understood, the fact that conditions promoting one also favor the other suggests related membrane active structural states. Here, a novel high throughput screening protocol is described that capitalizes on this correlation to identify compounds that target membrane active species. Applied to a small library of 960 known bioactive compounds, we are able to report identification of 37 compounds of which 36 were not previously reported as active toward IAPP fiber formation. Several compounds tested in secondary cell viability assays also demonstrate cytoprotective effects. It is a general observation that peptide induced toxicity in several amyloid diseases (such as Alzhiemer's and Parkinson's) involves a membrane bound, preamyloid oligomeric species. Our data here suggest that a screening protocol based on lipid-catalyzed assembly will find mechanistically informative small molecule hits in this subclass of amyloid diseases.

Original languageEnglish (US)
Pages (from-to)1341-1348
Number of pages8
JournalProtein Science
Volume23
Issue number10
DOIs
StatePublished - Oct 1 2014

Fingerprint

Islet Amyloid Polypeptide
Amyloid
Screening
Lipids
Molecules
Membranes
Toxicity
Cells
Lipid bilayers
Fibers
Poisons
Depolarization
Lipid Bilayers
Cell membranes
Libraries
Pancreas
Assays
Cell Survival
Cell Death
Agglomeration

Keywords

  • amylin
  • amyloid
  • high throughput screen
  • HTF
  • IAPP
  • lipids
  • small molecules
  • toxicity
  • Type 2 diabetes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Medicine(all)

Cite this

Small molecule screening in context : Lipid-catalyzed amyloid formation. / Hebda, James A.; Magzoub, Mazin; Miranker, Andrew D.

In: Protein Science, Vol. 23, No. 10, 01.10.2014, p. 1341-1348.

Research output: Contribution to journalArticle

Hebda, James A. ; Magzoub, Mazin ; Miranker, Andrew D. / Small molecule screening in context : Lipid-catalyzed amyloid formation. In: Protein Science. 2014 ; Vol. 23, No. 10. pp. 1341-1348.
@article{781f470897224846826afb872a385126,
title = "Small molecule screening in context: Lipid-catalyzed amyloid formation",
abstract = "Islet Amyloid Polypeptide (IAPP) is a 37-residue hormone cosecreted with insulin by the β-cells of the pancreas. Amyloid fiber aggregation of IAPP has been correlated with the dysfunction and death of these cells in type II diabetics. The likely mechanisms by which IAPP gains toxic function include energy independent cell membrane penetration and induction of membrane depolarization. These processes have been correlated with solution biophysical observations of lipid bilayer catalyzed acceleration of amyloid formation. Although the relationship between amyloid formation and toxicity is poorly understood, the fact that conditions promoting one also favor the other suggests related membrane active structural states. Here, a novel high throughput screening protocol is described that capitalizes on this correlation to identify compounds that target membrane active species. Applied to a small library of 960 known bioactive compounds, we are able to report identification of 37 compounds of which 36 were not previously reported as active toward IAPP fiber formation. Several compounds tested in secondary cell viability assays also demonstrate cytoprotective effects. It is a general observation that peptide induced toxicity in several amyloid diseases (such as Alzhiemer's and Parkinson's) involves a membrane bound, preamyloid oligomeric species. Our data here suggest that a screening protocol based on lipid-catalyzed assembly will find mechanistically informative small molecule hits in this subclass of amyloid diseases.",
keywords = "amylin, amyloid, high throughput screen, HTF, IAPP, lipids, small molecules, toxicity, Type 2 diabetes",
author = "Hebda, {James A.} and Mazin Magzoub and Miranker, {Andrew D.}",
year = "2014",
month = "10",
day = "1",
doi = "10.1002/pro.2518",
language = "English (US)",
volume = "23",
pages = "1341--1348",
journal = "Protein Science",
issn = "0961-8368",
publisher = "Cold Spring Harbor Laboratory Press",
number = "10",

}

TY - JOUR

T1 - Small molecule screening in context

T2 - Lipid-catalyzed amyloid formation

AU - Hebda, James A.

AU - Magzoub, Mazin

AU - Miranker, Andrew D.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Islet Amyloid Polypeptide (IAPP) is a 37-residue hormone cosecreted with insulin by the β-cells of the pancreas. Amyloid fiber aggregation of IAPP has been correlated with the dysfunction and death of these cells in type II diabetics. The likely mechanisms by which IAPP gains toxic function include energy independent cell membrane penetration and induction of membrane depolarization. These processes have been correlated with solution biophysical observations of lipid bilayer catalyzed acceleration of amyloid formation. Although the relationship between amyloid formation and toxicity is poorly understood, the fact that conditions promoting one also favor the other suggests related membrane active structural states. Here, a novel high throughput screening protocol is described that capitalizes on this correlation to identify compounds that target membrane active species. Applied to a small library of 960 known bioactive compounds, we are able to report identification of 37 compounds of which 36 were not previously reported as active toward IAPP fiber formation. Several compounds tested in secondary cell viability assays also demonstrate cytoprotective effects. It is a general observation that peptide induced toxicity in several amyloid diseases (such as Alzhiemer's and Parkinson's) involves a membrane bound, preamyloid oligomeric species. Our data here suggest that a screening protocol based on lipid-catalyzed assembly will find mechanistically informative small molecule hits in this subclass of amyloid diseases.

AB - Islet Amyloid Polypeptide (IAPP) is a 37-residue hormone cosecreted with insulin by the β-cells of the pancreas. Amyloid fiber aggregation of IAPP has been correlated with the dysfunction and death of these cells in type II diabetics. The likely mechanisms by which IAPP gains toxic function include energy independent cell membrane penetration and induction of membrane depolarization. These processes have been correlated with solution biophysical observations of lipid bilayer catalyzed acceleration of amyloid formation. Although the relationship between amyloid formation and toxicity is poorly understood, the fact that conditions promoting one also favor the other suggests related membrane active structural states. Here, a novel high throughput screening protocol is described that capitalizes on this correlation to identify compounds that target membrane active species. Applied to a small library of 960 known bioactive compounds, we are able to report identification of 37 compounds of which 36 were not previously reported as active toward IAPP fiber formation. Several compounds tested in secondary cell viability assays also demonstrate cytoprotective effects. It is a general observation that peptide induced toxicity in several amyloid diseases (such as Alzhiemer's and Parkinson's) involves a membrane bound, preamyloid oligomeric species. Our data here suggest that a screening protocol based on lipid-catalyzed assembly will find mechanistically informative small molecule hits in this subclass of amyloid diseases.

KW - amylin

KW - amyloid

KW - high throughput screen

KW - HTF

KW - IAPP

KW - lipids

KW - small molecules

KW - toxicity

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84920557987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920557987&partnerID=8YFLogxK

U2 - 10.1002/pro.2518

DO - 10.1002/pro.2518

M3 - Article

VL - 23

SP - 1341

EP - 1348

JO - Protein Science

JF - Protein Science

SN - 0961-8368

IS - 10

ER -